Viral, immune, and host genetic factors influence both a person's risk of becoming infected with HIV-1, and the rate at which the disease progresses once infected. We have recently determined that macrophage- tropic primary isolates of HIV-1 will not infect CD4+ peripheral blood mononuclear cells from some multiply-exposed seronegative persons. We have now identified the mechanism underlying this in vitro and in vivo resistance to infection. These individuals have inherited a homozygous 32-base-pair deletion within the gene encoding CCR-5, the major co- receptor for macrophage-tropic virus. Our most recent studies suggest that up to 25% of Caucasian high-risk seronegative homosexual men may have resisted HIV-1 infection because they inherited this allele. We hypothesize that this and other CCR-5 polymorphisms influence both one's risk of becoming infected with HIV-1 and the rate at which the disease progresses once infected. The overall goal of this proposal is to determine the extent to which naturally-occurring CCR-5 polymorphisms affect susceptibility to HIV-1 infection and disease progression world-wide. In addition, the immunologic function of cells expressing these CCR-5 polymorphisms will be tested.
The specific aims of the proposal are to: 1. Determine the role of the 32-bp deleted allele in HIV-1 transmission and disease progression. 2. Find other polymorphisms of CCR-5, determine their role in transmission and disease progression, and understand their evolution. 3. Determine the mechanism by which CCR-5 polymorphisms control resistance to infection and rates of disease progression. 4. Determine the immunologic consequences of inheritance of CCR-5 polymorphisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042397-04
Application #
6171110
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Program Officer
Plaeger, Susan F
Project Start
1997-05-01
Project End
2002-04-30
Budget Start
2000-05-01
Budget End
2001-04-30
Support Year
4
Fiscal Year
2000
Total Cost
$394,974
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Holland, Anne U; Munk, Carsten; Lucero, Ginger R et al. (2004) Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion. Virology 319:343-52
Munk, Carsten; Wei, Ge; Yang, Otto O et al. (2003) The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses 19:875-81
Brandt, Stephanie M; Mariani, Roberto; Holland, Anne U et al. (2002) Association of chemokine-mediated block to HIV entry with coreceptor internalization. J Biol Chem 277:17291-9
Munk, Carsten; Brandt, Stephanie M; Lucero, Ginger et al. (2002) A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci U S A 99:13843-8
Aarons, E J; Beddows, S; Willingham, T et al. (2001) Adaptation to blockade of human immunodeficiency virus type 1 entry imposed by the anti-CCR5 monoclonal antibody 2D7. Virology 287:382-90
Paxton, W A; Liu, R; Kang, S et al. (1998) Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines. Virology 244:66-73
Benkirane, M; Jin, D Y; Chun, R F et al. (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32. J Biol Chem 272:30603-6